Patents by Inventor Takashi ICHII

Takashi ICHII has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210179671
    Abstract: An affinity carrier may have improved alkali resistance. An immunoglobulin-binding protein containing a mutant polypeptide chain, as well as an affinity carrier containing a solid-phase carrier to which the immunoglobulin-binding protein is bound, may be a mutant polypeptide chain having an amino acid sequence having at least 85% identity to an amino acid sequence indicated by any of SEQ ID NO: 1-6 and 57-62, having a predetermined mutation, and having immunoglobulin-binding activity.
    Type: Application
    Filed: August 23, 2019
    Publication date: June 17, 2021
    Applicants: JSR CORPORATION, JSR MICRO INC., JSR MICRO N.V.
    Inventors: Tomoaki HAGA, Takashi ICHII, Shunsuke ONOGI, Satoshi NAKAMURA, Toshinari HONDA, Tomoyuki KAMIDE
  • Patent number: 10766924
    Abstract: To provide an affinity support in which a binding property of a ligand to a target substance is improved. The affinity support contains a solid phase support and a protein ligand, wherein the protein ligand is represented by formula (1): R—R1 (1) wherein R represents a linker binding to the solid phase support, which contains a polyproline, and R1 represents a protein showing an affinity to immunoglobulin, and the R is bound to a C terminal or an N terminal of an amino acid sequence in R1.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: September 8, 2020
    Assignees: JSR CORPORATION, JSR LIFE SCIENCES CORPORATION
    Inventors: Takashi Ichii, Satoshi Nakamura, Jun-ichi Yasuoka, Kaori Itaya, Tomonori Shiotani
  • Patent number: 10723769
    Abstract: Provided is an affinity chromatography carrier that maintains high immunoglobulin-binding capacity and high alkali resistance. An immunoglobulin-binding protein including at least one modified immunoglobulin-binding domain, the modified immunoglobulin-binding domain being a polypeptide consisting of an amino acid sequence of an immunoglobulin-binding domain selected from the group consisting of the B domain, Z domain, C domain, and variants thereof of Staphylococcus aureus protein A, in which at least one amino acid residue is inserted between positions corresponding to the 3-position and position 4 of the amino acid sequence of the B domain, Z domain or C domain.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: July 28, 2020
    Assignees: JSR CORPORATION, JSR LIFE SCIENCES CORPORATION
    Inventors: Jun-ichi Yasuoka, Takashi Ichii, Satoshi Nakamura, Tomonori Shiotani, Kaori Itaya
  • Publication number: 20180222939
    Abstract: To provide an affinity support in which a binding property of a ligand to a target substance is improved. The affinity support contains a solid phase support and a protein ligand, wherein the protein ligand is represented by formula (1): R—R1 (1) wherein R represents a linker binding to the solid phase support, which contains a polyproline, and R1 represents a protein showing an affinity to immunoglobulin, and the R is bound to a C terminal or an N terminal of an amino acid sequence in R1.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 9, 2018
    Applicants: JSR CORPORATION, JSR LIFE SCIENCES CORPORATION
    Inventors: Takashi ICHII, Satoshi NAKAMURA, Jun-ichi YASUOKA, Kaori ITAYA, Tomonori SHIOTANI
  • Publication number: 20180105560
    Abstract: Provided is an affinity chromatography carrier that maintains high immunoglobulin-binding capacity and high alkali resistance. An immunoglobulin-binding protein including at least one modified immunoglobulin-binding domain, the modified immunoglobulin-binding domain being a polypeptide consisting of an amino acid sequence of an immunoglobulin-binding domain selected from the group consisting of the B domain, Z domain, C domain, and variants thereof of Staphylococcus aureus protein A, in which at least one amino acid residue is inserted between positions corresponding to the 3-position and position 4 of the amino acid sequence of the B domain, Z domain or C domain.
    Type: Application
    Filed: March 24, 2016
    Publication date: April 19, 2018
    Applicants: JSR CORPORATION, JSR LIFE SCIENCES CORPORATION
    Inventors: Jun-ichi YASUOKA, Takashi ICHII, Satoshi NAKAMURA, Tomonori SHIOTANI, Kaori ITAYA